Browsing: Weight Loss

Health Canada’s recent approval of weight loss drug Zepbound as a treatment for obstructive sleep apnea in obese adults could create financial risks for benefits plan sponsors, says Joseph Koo, assistant vice-president of health solutions and national pharmacist at Aon

A clinical trial is recruiting adults with type 2 diabetes to test a new long-lasting amylin drug for weight management

The device could cost less than injections, but coverage stays unclear in a US$100 billion GLP-1 market

July 13, 2026 ByLeslie Goldman, MPH, Health Writer

Eli Lilly is the leader in the weight loss drug market — a market on track to reach almost $100 billion

The growing popularity of GLP-1 medications such as Ozempic, Wegovy, and Rybelsus has largely been driven by their ability to help people lose weight, improve blood sugar control, and reduce the risk of cardiovascular disease. Now, researchers have uncovered another possible benefit. A new clinical trial suggests that semaglutide, the active ingredient in those medications,…

Poolbeg Pharma (LSE:POLB) has raised £3.5 million through a placing of 58.3 million new ordinary shares at 6 pence each, representing a 16% discount to the previous closing price. Executive Chair Cathal Friel participated in the fundraising with a £250,000 investment

Uzbekistan has the highest share of overweight adults in Central Asia and now ranks first among CIS countries on the indicator

A pharmacist has warned that patients interested in the new Wegovy pill may not be getting the full picture on the strict rules, side effects, and safety risks linked to the once-daily tablet. The tablet, which contains semaglutide, has been approved in the UK for weight loss and weight management, creating a new oral form…

In the never-ending race for skinny, it seems a thriving black market in illegal weight-loss jabs has developed in South Africa